Organic & Biomolecular Chemistry
Communication
In conclusion, we have demonstrated a new approach to
construct the synthetically and biologically important 4-methyl
and 4-methoxy tetrahydro-γ-carboline compounds from the
readily available 5-amino-3-oxopentanoate derivatives and sub-
stituted anilines. The most crucial step is the oxidative annula-
tion, which can be realized by either Pd-catalyzed or PhI(OAc)2-
mediated C–C bond oxidative formation, with the former
method furnishing the cyclized product in better yields. It can
be envisaged that by starting off with different arylamines, this
method provides convenient access to a variety of tetrahydro-
γ-carboline derivatives containing different substituents on the
phenyl ring.
Scheme 4 An alternative synthetic protocol. aReagents and conditions: (a) 2,
DCC, CH2Cl2, rt, 91%; (b) EtONa, EtOH, 80 °C, 84%; (c) 5% HCl (aq.), 80 °C, 58%;
(d) 6a, AcOH, rt 92%; (e) Method A: Pd(OAc)2 (10%), Cu(OAc)2, K2CO3, DMF,
80 °C, 66%; Method B: PhI(OAc)2, DCE, −20 °C to −60 °C, 0%.
of screening tests of the various conditions/parameters includ-
ing the types of bases, the reaction temperature and the
Acknowledgements
solvent. To our delight, we found that the use of sodium Y. Du acknowledges the National Natural Science Foundation
hydroxide in methanol at reflux temperature could furnish the of China (#21072148) and the Cultivation Foundation (B) for
desired lactam 9a or 9b in 92% or 95% yields, respectively. Young Faculty of Tianjin University (TJU-YFF-08B68) for finan-
Finally, lactams 9a and 9b underwent smooth carbonyl cial support.
reduction by using LiAlH4 in THF to give the target compound,
tetrahydro-γ-carboline 10a and 10b, respectively, in satisfactory
yield.21
Notes and references
We also tested an alternative synthetic protocol in which
the lactamization occurs before the formation of the indole
ring (Scheme 4). The enamination of 14 with arylamine 6a
afforded the enamine intermediate 15 in 92% yield,17 and the
oxidative C(sp2)–C(sp2) bond formation in 15 was again
realized by using Glorius’s method, but with a lower yield of 66%
in comparison to the case of intermediate 7.11a,b However, this
method suffers a significant disadvantage as the crucial inter-
mediate, 1-methylpiperidine-2,4-dione (14), is not readily avail-
able and its preparation by the known methods22 proved to be
less efficient with an overall yield of only 38% starting from
methylamine and methyl acrylate. Furthermore, the oxidative
annulation of 15 was also tested by our own transition metal-
free approach,12 but afforded an inseparable complex mixture
even at lower temperature.
Both methods of the transition metal and the hypervalent
iodine reagent can convert various N-aryl enamine substrates
into their corresponding indole products through oxidative
C–C bond formation, with the requirement that the N-aryl
enamine compound bear one or more electron-withdrawing
groups such as cyano, ester or acyl groups, as their presence is
essential for keeping the enamine configuration of the sub-
strates. However, the hypervalent iodine reagent was also
found to be applicable to the synthesis of 3-nitroindole from
the N-aryl β-nitroenamine compound. On comparing the two
methods, the transition metal method offers the advantage of
tolerating a variety of substituents on the aromatic ring of the
N-aryl enamine reactant, including nitro, cyano, amide,
hydroxyl and trifluoromethyl groups. Furthermore, the oxi-
dative annulation of cyclic N-aryl enamines was found to be
achieved exclusively by the former method while our metal-
free approach proved to be ineffective for this class of cyclic
substrates.23
1 (a) A. V. Ivachtchenko, E. B. Frolov, O. D. Mitkin,
V. M. Kysil, A. V. Khvat, I. M. Okun and S. E. Tkachenko,
Bioorg. Med. Chem. Lett., 2009, 19, 3183; (b) M. Gao and
M. Wang, Bioorg. Med. Chem. Lett., 2010, 20, 2529;
(c) P. R. Bharadwaj, G. Verdile, R. K. Barr, V. Gupta,
J. W. Steele, M. L. Lachenmayer, Z. Yue, M. E. Ehrlich,
G. Petsko and S. Ju, J. Alzheimers Dis., 2012, 32, 949.
2 (a) K. V. Butler, J. Kalin, C. Brochier, G. Vistoli, B. Langley
and A. P. Kozikowski, J. Am. Chem. Soc., 2010, 132, 10842;
(b) J. H. Kalin, K. V. Butler, T. Akimova, W. W. Hancock and
A. P. Kozikowski, J. Med. Chem., 2012, 55, 639.
3 (a) S. Gore, S. Baskaran and B. König, Org. Lett., 2012, 14,
4568; (b) L. Zhang, W. Meier, E. Wats, T. D. Costello, P. Ma,
P. O. Ensinger, J. M. Rodgers, I. C. Jacobson and
P. Rajagopalan, Tetrahedron Lett., 1995, 36, 8387;
(c) Rajagopalan and Parthasarathi, WO1994003455,
PCT/US1993/006823, 1994.
4 L. Ye, Y. Tian, Z. Li, J. Zhang and S. Wu, Helv. Chim. Acta,
2012, 95, 320.
5 A. Bridoux, J. Pommery, N. Pommery and J. P. Henichart,
Bioorg. Med. Chem., 2010, 18, 3910.
6 I. T. Schiefer, L. VandeVrede, M. Fa’, O. Arancio and
G. R. J. Thatcher, J. Med. Chem., 2012, 55, 3076.
7 (a) S. L. Bascop, B. Sapi, J. Y. Laronze and J. Lévy, Hetero-
cycles, 1994, 38, 725; (b) J. A. Murphy, R. Tripoli, T. A. Khan
and U. W. Mali, Org. Lett., 2005, 7, 3287; (c) B. M. Trost and
M. K. Brennan, Org. Lett., 2006, 8, 2027; (d) V. J. Reddy and
C. J. Douglas, Org. Lett., 2011, 13, 3288.
8 (a) C. A. Harbert, J. J. Plattner, W. M. Welch, A. Weissman
and B. K. Koe, J. Med. Chem., 1980, 23, 635; (b) K. V. Butler,
J. Kalin, C. Brochier, G. Vistoli, B. Langley and
A. P. Kozikowski, J. Am. Chem. Soc., 2010, 132, 10842;
This journal is © The Royal Society of Chemistry 2013
Org. Biomol. Chem., 2013, 11, 1929–1932 | 1931